Torbay Pharmaceuticals

About Torbay Pharmaceuticals

Torbay Pharma focuses on  research, development, manufacturing and marketing of injectable, terminally sterilised generic pharmaceutical products for secondary care. We work as CDMO/CMO for some of the worlds largest pharmaceutical companies, with a significant presence is the North American market.

Additionally, Torbay has a wide portfolio of injectable products, both licensed and unlicensed and is looking for partners in and outside of Europe for the distribution and marketing of those products. 


Torbay's key areas of focus are the continued development of our CDMO/CMO business and the licensing and out-licensing of our existing and pipeline of injectable medicines.

  • GB
  • 2021
    On CPHI since
  • 250 - 499
    Employees
Contact info
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024